Katy Gardner is the practice group leader of the Firm’s U.S. Corporate Practice Group. Katy represents domestic and foreign corporations, partnerships, and limited liability companies in their mergers and acquisitions, other business and financial transactions, and in their day-to-day operations. Katy has broad-based experience in structuring transactions, drafting and negotiating various transactional documents in connection with asset sales and acquisitions, stock acquisitions, mergers, private placements, venture capital transactions, hedge funds, and lending transactions. She represents entities in diverse industries, including life sciences, government contracts, hedge funds, media, technology, manufacturing, and trade associations.
In addition, Katy represents investors, issuers, lenders, and borrowers in their funding activities, including joint ventures, equity investments, and senior secured and mezzanine financings. She has structured various domestic and offshore hedge funds and private equity funds. As counsel to the funds, she continues to represent them in the purchase and sale of assets held by the funds and in other day-to-day fund activities.
Representation
The majority shareholders of Invacare, a medical equipment manufacturer, in a refinancing and restructuring.
Lupin Limited, in connection with its $880 million acquisition of Gavis Pharmaceuticals and its affiliates.
Lupin, Inc., in connection with its purchase of Symbiomix Therapeutics.
Listed medical device company in connection with investments in, options to acquire and acquisitions of privately-held medical device companies.
Listed investment company in connection with acquisition of group of affiliated residential mortgage companies.
Regularly represents public and private companies in connection with the strategic acquisitions and dispositions ranging in value from $10 million to more than $1 billion.
Represents investors, including hedge, private equity and real estate funds in connection with portfolio acquisitions, dispositions and joint ventures.
Education
Bar Admissions
News |
Publications |
Speaking Engagements |
Firm Activities |
© 2025 Brown Rudnick LLP. Attorney Advertising